Dr. Flynn’s research interests focus on the development of cell-based regenerative approaches with adipose-derived stem cells (ASCs) and naturally-derived bioscaffolds for applications in musculoskeletal regeneration (adipose tissue, cartilage, ligament and intervertebral disc). She has recently filed patents pertaining to novel biomaterials fabricated from decellularized adipose tissue (DAT) and is working towards the commercialization of the DAT technology for use soft tissue reconstruction and augmentation. With a focus on translational research, Dr. Flynn's team works closely with an interdisciplinary network of collaborators including scientists, engineers and clinicians.

In 2012, Dr. Flynn was the recipient of an Early Researcher Award from the province of Ontario, and her research has been supported through operating grants from the Canadian Institutes of Health Research (CIHR), the Natural Sciences and Engineering Research Council of Canada (NSERC), the Heart and Stroke Foundation of Ontario (HSFO) and the Ontario Centres of Excellence (OCE).